Stemtech Corp (STEK): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$10.59M

As of 2025-12-31

$11.11M

As of 2026-06-30

2017-08-31 Total Liabilities (USD) 2025-12-31

Period ended	Total Liabilities	Change YoY	Source filing
2025-12-31	$10.59M	+21.1%	2026-05-29, Balance as of period end
2024-12-31	$8.74M	n/c	2026-05-29, Balance as of period end
2023-12-31	$6.46M	-13.1%	2025-06-30, Balance as of period end
2022-12-31	$7.44M	-23.5%	2024-07-10, Balance as of period end
2021-12-31	$9.73M	+159.9%	2023-04-17, Balance as of period end
2020-12-31	$3.74M	n/a	2022-04-01, Balance as of period end
2020-08-31	$272.2K	+40.1%	2020-12-14, Balance as of period end
2019-08-31	$194.3K	+12.7%	2020-12-14, Balance as of period end
2018-08-31	$172.4K	+25.5%	2019-12-13, Balance as of period end
2017-08-31	$137.4K	n/a	2018-12-14, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Total Liabilities	Change YoY
Stemtech Corp (STEK)	2025-12-31	$10.59M	+21.1%
DataMeds AI, Inc. (MEDS)	2025-12-31	$42.91M	-15.2%
Cosmos Health Inc. (COSM)	2025-12-31	$47.05M	+58.0%
Nu Skin Enterprises, Inc. (NUS)	2025-12-31	$600.07M	-26.6%
Herbalife Ltd. (HLF)	2025-12-31	$3.30B	-6.6%

Compare STEK, MEDS, COSM, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗